Ryman Healthcare [NZX: RYM], the country's biggest listed retirement village operator and developer, has bought land in Wellington which it plans to turn into a boutique village.
The Christchurch-based company has bought a 6,000 square metre site in Newtown from supermarket operator Foodstuffs for an undisclosed sum, which it will develop into a new village with independent and serviced apartments, and resthome, hospital and dementia care, it said in a statement. The village will be Ryman's sixth in the Wellington area.
"It's a great site with terrific views across the city, and it is close to public transport, shops, and the hospital," managing director Simon Challies said. "Wellington has a rapidly growing ageing population in line with the rest of the country."
Ryman owns and operates 27 retirement villages housing 7,500 residents. Like other retirement village developers and operators, Ryman is looking to latch on to an ageing demographic, and has increased its annual building target to 850 beds and units a year in New Zealand by 2017, from a rate of 700 a year.
The shares were unchanged at $8.53, and have gained 8.7 percent this year. The stock is rated an average 'hold' based on six analyst recommendations compiled by Reuters, with a median target price of $8.25.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- NZ dollar gains as upbeat data across Asia spurs US dollar selling
- Key leads move against fossil fuel subsidies at Paris climate summit
- Political and economic week ahead: Labour party reshuffle
- Yoghurt Story promoted products that did not contain yoghurt – ComCom
- Opportunity to own a slice of prehistoric New Zealand
Most listened to
- Hellaby’s oil & gas services business could deliver this year, says new managing director Alan Clarke
- Hamish McNicol talks about Yoghurt Story
- TrueNet's John Butt on internet speeds
- Snakk Media chief executive Mark Ryan wonders how to "move the needle" on Snakk's share price
- Head-to-head: Federated Farmers director Katie Milne and SAFE executive director Hans kriek debate dairy industry's treatment of bobby calves